|
Title
|
Published
|
Price
|
|
Oncology Market Forecast to 2013
By: Cutting Edge Information
Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created
Cutting Edge Information's new report, "Oncology Market Forecast to 2013," explores the fiercely competitive oncology market in a way that no other available
|
more...
|
6/25/2008
|
$7,695.00
|
|
Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI
By: Cutting Edge Information
Solidify competitive intelligence’s presence to optimize decision making
Pharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas.
|
more...
|
6/15/2008
|
$7,695.00
|
|
The Changing MSL Role: Proving Value Through Performance Measurement
By: Cutting Edge Information
Revolutionize your MSL teams to help drive bottom-line results:
In the past, medical science liaisons (MSLs) served a traditional role as scientific support to sales. But market realities, including fewer drug approvals and increasing regulatory
|
more...
|
6/15/2008
|
$7,695.00
|
|
Investigator-Initiated Trials: Building Superior IIT Capabilities
By: Cutting Edge Information
Establish and perfect internal controls to capitalize on IIT opportunities
Investigator-initiated clinical trials (IITs) provide companies with the clinical data to further scientific understanding of their drugs. IIT findings help to expand on- and
|
more...
|
4/1/2008
|
$7,695.00
|
|
In Vitro Diagnostics: Development Through Postmarket
By: Cutting Edge Information
Make the most of limited resources by benchmarking IVDs' budgets and staff support for development, marketing, reimbursement and sales.
To achieve commercial success, in vitro diagnostic (IVD) companies must earn the approval of
|
more...
|
4/1/2008
|
$7,695.00
|
|
A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy
By: Cutting Edge Information
Increase the effectiveness of your LCM Strategies:
With pipelines diminishing and generics becoming more aggressive, pharmaceutical companies must maximize their brands’ value and time on the market. Strategic and well-orchestrated lifecycle management efforts are
|
more...
|
3/28/2008
|
$7,695.00
|
|
Thought Leader Compensation: Establishing Fair-Market Value Procedures
By: Cutting Edge Information
Create your own fee schedules by exploring fair-market value benchmarks for 20 therapeutic areas and multiple specialties:
Fair-market value has been a notoriously difficult concept to master, especially since there are no defined regulations or
|
more...
|
12/31/2007
|
$7,695.00
|
|
Pharmaceutical Opinion Leader Management: Cultivating Today's Influential Physicians for Tomorrow
By: Cutting Edge Information
Explore detailed segmentation data, budgets and headcounts for thought leader management and MSL programs:
Identifying and recruiting key opinion leaders is a challenging task in and of itself. But what are the best strategies
|
more...
|
11/1/2007
|
$7,695.00
|
|
Canadian Pharmaceutical Sales Management
By: Cutting Edge Information
In Canada, access to physicians remains one of the top problems of the day for pharmaceutical sales organizations. Though not nearly as overrun as US doctors, top prescribing Canadian physicians can still expect to see
|
more...
|
11/1/2007
|
$7,695.00
|
|
Combating Generics 2008: Counter-Generics Strategy, Tactics and Execution (PH105)
By: Cutting Edge Information
Generic drugs now account for more than 60% of all prescriptions filled in the US, and more than $60 billion worth of drugs face US patent expiration by 2011.
Use this report to
|
more...
|
10/1/2007
|
$7,695.00
|
|
Pharmaceutical Sales Management 2008 (PH103)
By: Cutting Edge Information
Though the sales arms race is over, reps still overcrowd doctors’ waiting rooms today. Although the “more is better” selling technique employed by the largest of pharmas was successful through the late 1990’s and early
|
more...
|
9/1/2007
|
$7,695.00
|
|
Pharmaceutical Medical Publications: Market Preparation & Strategic Support
By: Cutting Edge Information
Increase the effectiveness of your medical publications:
Medical publications play such an integral to many company’s overall strategies. Publications not only provide substantial value to clinical studies and research data, but also serve as
|
more...
|
9/1/2007
|
$7,695.00
|
|
Developing Integrated Market Research Functions for 2008 (PH102)
By: Cutting Edge Information
Examine market research departments’ structures, budgets and staffing levels -- and the challenges they face in supporting strategic decisions (PH102)
Traditionally, market research teams were buried within the marketing organization, relegated to marketing support status
|
more...
|
8/1/2007
|
$7,695.00
|
|
Pharmacoeconomics and Health Outcomes: Driving Formulary Access and Reimbursement (PH99)
By: Cutting Edge Information
With ever-increasing pressures from managed care organizations, government agencies, pharmacy benefit managers and other reimbursement groups for pharmaceutical companies to prove their products’ value, pharmacoeconomics is a becoming a more and more important science. Empowered
|
more...
|
6/1/2007
|
$7,695.00
|
|
Uniting R&D and Marketing for Integrated Early-Stage Market Preparation (PH100)
By: Cutting Edge Information
Bridge the structural, cultural, process and communications gaps between R&D and marketing in early-stage drug development:
Early-stage product commercialization continues to challenge even the most skilled and highly respected marketing and drug development organizations. Changing
|
more...
|
5/1/2007
|
$7,695.00
|
|
PH96 - Pharmaceutical Customer Relationship Management: Developing and Improving CRM
By: Cutting Edge Information
Uncover CRM strategies, structure, spending and staffing:
As the pharmaceutical industry focuses on maximizing the lifetime value of customers and physicians, customer relationship management plays an increasingly important role. This study examines several top companies’
|
more...
|
4/1/2007
|
$7,695.00
|
|
PH98 - Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies
By: Cutting Edge Information
Uncover the decisions, investments and timing behind successful relaunch strategies:
Product teams must begin their relaunch planning early to incorporate it into a strong overall lifecycle management strategy. As product teams enter Phase 2 of
|
more...
|
4/1/2007
|
$7,695.00
|
|
Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch (PH95)
By: Cutting Edge Information
Fund early-stage marketing to realize products' commercial potential:
Some project and brand teams make a critical mistake early in their drugs’ development lifecycles - they fail to adequately prepare the market for their products. Early-stage
|
more...
|
3/1/2007
|
$7,695.00
|
|
PH94 - Patient Education and Direct-to-Patient Communication
By: Cutting Edge Information
Explore benchmark data from 20 patient education programs.
Reach consumers and gain the trust of physicians with direct-to-patient (DTP) communications that feature user-friendly, unbiased patient education content.
Use this report to explore benchmark data from
|
more...
|
2/1/2007
|
$7,695.00
|
|
Post-Launch Brand Marketing in Select Affiliate Markets
By: Cutting Edge Information
Uncover real-world brand budgets from the first three years on the market:
Explore marketing budgets for 8 brands throughout their first, second and third years of market availability. The brands are marketed in the
|
more...
|
1/1/2007
|
$3,295.00
|
|
Mastering Phase IV Clinical Trials
By: Cutting Edge Information
Enhance Your Post-Marketing Trials:
Phase 4 is the fastest-growing area of clinical research today. At an annual growth rate of 23%, industry investment in post-marketing research is expected to top $12 billion in 2007.
|
more...
|
1/1/2007
|
$7,695.00
|
|
US Launch: Phase IIIa, Phase IIIb and Launch Year Brand Commercialization (PH93)
By: Cutting Edge Information
Increasingly stiff competition combined with enormous market pressures that shorten brand timelines make achieving a drug’s full sales potential much more difficult in today's pharmaceutical environment. Brand leaders must be finely attuned to their brands’
|
more...
|
1/1/2007
|
$7,695.00
|
|
Pharmaceutical Patient Adherence and Disease Management: Program Development, Management and Improvement (PH90)
By: Cutting Edge Information
This report provides benchmarks for patient adherence and disease management organizational structures, resource investments, tactics and improvement processes. Explore some of the industry's most innovative programs, from leadership involvement to budgets to common program challenges.
|
more...
|
11/1/2006
|
$7,695.00
|
|
Pharmaceutical Sales Training Groups: Building Better Sales Forces (PH89)
By: Cutting Edge Information
Cutting Edge Information developed this study to research pharmaceutical companies’ sales training departments and programs. The report examines sales training department structures, leadership, spending and improvement strategies, along with individual sales department training programs.
|
more...
|
11/1/2006
|
$3,295.00
|
|
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance Environment
By: Cutting Edge Information
Pharmaceutical CME departments struggle to measure performance for a number of reasons. The lack of hard measures for medical education, along with a fear of appearing non-compliant stops many companies from tracking return on investment
|
more...
|
9/1/2006
|
$4,395.00
|
|
Title
|
Published
|
Price
|
(0 items)
